Cytosolic aspartate aminotransferase (cAspAT) participates in gluconeogenesis in the liver and is expected to exert a glyceroneogenic function in the adipose tissue when the supply of glucose is limited. Here we demonstrate that adipose cAspAT messenger RNA (mRNA) is increased when rats are fed a low carbohydrate diet. In the 3T3-F442A, BFC-1 adipocyte cell lines and differentiated adipocytes in primary culture, a 24 h glucose deprivation induces approximately a 4-fold increase in cytosolic AspAT (cAspAT) mRNA, whereas mitochondrial AspAT mRNA remains unchanged. cAspAT activity is also increased in a weaker but reproducible manner. Addition of glucose within a physiological range of concentrations reverses the increase of cAspAT mRNA in 8 h (EC 50 ϭ 1.25 g/liter). Such a regulation requires protein synthesis and is specific for adipocytes differentiated in culture. It does not occur in Fao or H4IIE hepatoma cells, in C2 muscle cells, or in 293 kidney cells. 2-deoxyglucose mimicks glucose, while 3-orthomethyl-glucose has no effect, suggesting that glucose-6-phosphate is the effector. cAspAT mRNA stability is not affected by glucose deprivation. To ascertain the transcriptional nature of the glucose effect, we have stably transfected 3T3-F442A adipoblasts with constructs containing the chloramphenicol acetyltransferase reporter gene under the control of either 5Ј-deletions of the cAspAT gene promoter or internal fragments in an heterologous context. We demonstrate that a glucose response element(s) is present in the region between Ϫ1838 and Ϫ1702 bp relative to the translation start site. In this region, three DNA sequences bind nuclear proteins from adipocytes as shown by footprinting experiments. Our results indicate that cAspAT gene transcription is repressed by glucose selectively in adipocytes. (Endocrinology 139: 4936 -4944, 1998) 
G
LUCOSE regulates the expression of several genes that encode metabolic enzymes. It has been postulated that these effects of glucose mediate the regulation of several genes by insulin. Most studies have dealt with positive regulation as in the case of the L-type pyruvate kinase (L-PK). In liver and in cultured hepatocytes, glucose induces the expression of the L-PK gene via a glucose response element (GlRE) present in the promoter of the gene (1) (2) (3) (4) . This GlRE consists of two palindromic binding sites for upstream stimulating factor (USF) proteins separated by 5 bp (3). However, the implication of this transcription factor in glucose regulation is controversial (5) . An element with a similar structure, termed carbohydrate response element, has also been identified in the regulatory region of the spot 14 gene (6, 7).
Conversely, glucose inhibits phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32; PEPCK) gene expression in hepatocytes (8) , hepatoma cells (9) and cultured white adipose tissue (10) and represses the stimulation of fatty acidinduced PEPCK messenger RNA (mRNA) in adipocytes (11) , through still undeciphered mechanisms. In cultured adipose tissue, glucose stimulates fatty acid synthase and acetyl-CoA carboxylase mRNAs (10, 12) . Interestingly, all the genes of these enzymes are also under multihormonal control (10, 13, 14) . Hence, the interplay of nutrients and hormones results in a fine tuning of expression of these genes.
Cytosolic aspartate aminotransferase (cAspAT; EC 2.6.1.1) is a metabolic enzyme which participates in an ubiquitous function, the malate aspartate shuttle and in gluconeogenesis, a tissue-specific regulated pathway. Regulation of cAspAT gene expression has been extensively studied in liver and kidney. In these tissues cAspAT activity is induced by a low carbohydrate diet, starvation, diabetes, and hydrocortisone (15) (16) (17) . In cultured Fao hepatoma cells, glucocorticoids are strong stimulators of cAspAT activity, mRNA, and gene transcription. cAMP potentiates the glucocorticoid effect, whereas insulin inhibits it (18, 19) . None of these effectors affects the mitochondrial isoform of AspAT (mAspAT) , showing that the hormonal control is specific for cAspAT and consistent with the participation of the latter enzyme in gluconeogenesis.
cAspAT is also expressed in adipose tissue in which its physiological role is not clear. PEPCK, the rate limiting enzyme in hepatic gluconeogenesis, which yields phosphoenolpyruvate from oxaloacetate, is also expressed in adipose tissue where it performs a glyceroneogenic function when glucose supply to the tissue and glycolysis are low (20) . Because cAspAT allows the generation of oxaloacetate in the cytoplasm, it is postulated that it is also involved in glyceroneogenesis in adipose tissue under conditions of restrained glucose transport and utilization. We have previously shown that the cAspAT gene expression in 3T3-F442A adipocytes is raised by various conditions including glucose deprivation (21) . Here we demonstrate that adipose cAspAT mRNA is increased when rats are fed a low carbohydrate diet, and we analyze the mechanism by which glucose represses cAspAT gene expression in cultured 3T3-F442A adipocytes. This regulation appears specific to adipocytes and is exerted in a physiological range of glucose concentrations. In addition, we have localized the region of the promoter that mediates the negative glucose regulation of cAspAT gene expression.
Materials and Methods

Animals and diets
Male Wistar rats bred in our laboratory were used. They were housed in individual cages at a constant temperature of 24 C. Rats weighing 180 -200 g were used by groups of six animals. The first group received the high carbohydrate (HC) diet ad libitum for 11 days, the second group was fed the low carbohydrate (LC) diet for 11 days, and the third group received the LC diet for 10 days followed by 24 h of HC diet. The HC diet had the following composition (g/100 g of diet) sucrose (10), starch (60), casein (10), oil (8) , vitamin (1), mineral mixture (4), and cellulose (7). In the LC diet, sucrose and starch were replaced by casein. The periepididymal fat pads were removed, immediately frozen in liquid nitrogen and stored at Ϫ80 C for subsequent RNA extraction.
Cell culture and treatment
3T3-F442A and BFC-1 adipoblasts, C2.7 myoblasts, and 293 cells were cultured at 37 C in a humidified atmosphere of 10% CO 2 /90% air in DMEM containing 4.5 g/liter glucose, 200 IU/ml penicillin, 50 mg/liter streptomycin, 8 mg/liter biotin, 4 mg/liter pantothenate, 3.7 g/liter bicarbonate, and supplemented with 10% FCS (Medium A) for adipoblasts and 293 cells and with 20% FCS for myoblasts. Adipose differentiation was achieved in the same medium enriched with 0.02 m insulin for 8 days. C2.7 myocytes were obtained by culturing confluent cells in medium containing 1% FCS for 3 days. Fao and H4IIE hepatoma cells were cultured in Ham's F12 medium containing 1.26 g/liter glucose, 200 IU/ml penicillin, 50 mg/liter streptomycin, 3.7 g/liter bicarbonate and 10% FCS. Cells were shifted to serum-free, insulin-free medium for 24 h (or 48 h when indicated), during which treatment with effectors was performed for the indicated times before RNA extraction and assays of CAT or cAspAT activity. When glucose was omitted, medium was enriched with 1 mm pyruvate and 0.1 mm lactate. For primary cultures, inguinal adipose tissue from 3-day-old C57 BL/6J mice was cut in small fragments that were maintained at the bottom of a 60-mm diameter culture dish in 1 ml of medium A for 3 days to permit attachment. Explants were then cultured for 8 days in 4 ml of medium A to allow sufficient migration of the cells out the explants. Cells were then replated at a density of 3 ϫ 10 5 cells/60-mm dish and cultured in a manner identical to the 3T3-F442A cell line.
RNA extraction and analysis
Cells from two 60-mm dishes were pooled, and RNA was extracted according to the method of Chomczynski and Sacchi (22) . RNA extraction from adipose tissue was performed by the TriPure isolation reagent (Boehringer Mannheim) according to the manufacturer's instructions.
Total RNA was electrophoresed on a 1% agarose gel containing 2.2 m formaldehyde and blotted onto a nylon membrane. The integrity and relative amounts of RNA were assessed by methylene blue staining. Prehybridization and hybridization of the blots were performed according to Yang and colleagues (23) . Membranes were hybridized overnight at 65 C in 0.27 m NaCl, 1.5 mm EDTA, 15 mm sodium phosphate (pH 7.7) containing 7% SDS, 10% polyethylene glycol 6000, 250 g/ml sonicated salmon sperm DNA, 250 g/ml heparin and 10 6 cpm/ml of complementary DNA (cDNA) labeled with [␣ 32 P] dCTP (Amersham) by random priming according to the manufacturer's recommendation. Membranes were washed twice for 15 min at room temperature with 2 ϫ SSC (1 ϫ SSC is 0.3 m NaCl, 0.03 m sodium citrate, pH 7), 0.1% SDS and then for 30 min at 60 C with 0.1 ϫ SSC, 0.1% SDS. Specific cDNA probes used were the cAspAT (4B21) (16) , mAspAT (16) , PEPCK (PC116) (24) , S14 (PT76) (25) and ␤-actin (pA21). An oligonucleotide specific for the 18S ribosomal RNA was 32 P end-labeled and used as a control, as described previously (26) . The mRNA signal was quantified by scanning densitometry and was corrected for differences in RNA loading by comparison with the signals generated by the ␤-actin or the 18S rRNA probe.
Plasmid constructs
The p-2405/-26:CAT, p-1984/-26:CAT, p-1718/-26:CAT and p-300/-26:CAT were previously described (19) . In these constructs the Ϫ26 bp is relative to the translation start site (19) . The plasmid ⌬MTV:CAT, derived from the plasmid MMTV:CAT by deletion of the sequence from position [mins] 190 to Ϫ88 of the mouse mammary tumor virus long terminal repeat was a gift of Dr. R. Evans (San Diego, CA) and was described elsewhere (27) . The plasmids Ϫ1984/Ϫ1702⌬MTV:CAT, p-1984/-1702TK:CAT and p-1838/-1702TK:CAT were obtained by subcloning fragments of the cAspAT gene promoter obtained by PCR into the HindIII site of the p⌬MTV:CAT vector or of the pTK:CAT, which contains Ϫ105 bp of the herpes simplex thymidine kinase promoter linked to the CAT gene. These fragments were amplified from the p-2405/-26:CAT plasmid, using the primers 5Ј TAGTAGAAGCTTAG-GTCCAGGTTC 3Ј and 5Ј CTTCACAAGCTTAGGCAACAATGC 3Ј (for the Ϫ1984/Ϫ1702 fragment) and the primers 5Ј ATGTGCAAGCTTG-TACCTAACTGAA 3Ј and 5Ј CTTCACAAGCTTAGGCAACAATGC 3Ј (for the Ϫ1838/Ϫ1702 fragment) which, all, contain a HindIII site for the subcloning step.
Stable transfection experiments
Exponentially growing 3T3-F442A preadipocytes (10 5 cells per 100 mm plates) were cotransfected by calcium phosphate-DNA coprecipitation (28) with 2 g of pSV2-NEO (29), the expression of which confers resistance to the antibiotic geneticin together with 20 g of CAT-expressing plasmid. Cells were treated as described (30) . Transfection efficiency was about 5 ϫ 10
Ϫ5
. After 2 weeks exposure to geneticin (0.4 mg/ml), several colonies of geneticin-resistant cells were isolated and analyzed. Cells from 90% of these colonies were still able to differentiate at a frequency similar to that of the parental line. About 70% of these expressed CAT. Fully differentiated adipocytes were shifted to serumfree medium and deprived or not of glucose for the last 24 h before CAT assay.
Assay of cAspAT and of CAT activities
For the separate determination of cAspAT and mAspAT, we have used the procedure of Parli et al. (31) , which is based on the thermolability of mitochondrial but not cytosolic AspAT as previously described by Barouki et al. (18) . Preparation of cell homogenates for CAT assays was performed as detailed (32) . The method of Seed and Sheen (33) was used for CAT activity determination. One unit of CAT converts 1 mol chloramphenicol to butyryl-chloramphenicol per minute at pH 7.8 and 37 C.
DNase I footprinting
A probe from the cAspAT gene promoter (nucleotides Ϫ1838 to Ϫ1702) was end-labeled using the Klenow fragment of DNA polymerase I. The standard reaction was performed according to Vaulont et al. (34) with some modifications (35) . The nuclear proteins, 30 -60 g, prepared as mentioned previously (35) were incubated with about 1 ng of labeled probe (30,000 cpm) for 15 min on ice. After adjusting the concentration of CaCl 2 to 2.5 mm and incubating for 1 min at 20 C, DNase I was added, and the digestion was carried out at 20 C for 1 min. Subsequent handling of the DNA was performed as described (34) .
Results
Adipose cAspAT mRNA is increased by a low-carbohydrate diet in vivo and by glucose deprivation in 3T3-F442A cells
Cytosolic aspartate aminotransferase is expressed in vivo in all tissues analyzed so far. However, expression of the cAspAT gene has been mainly studied in liver and in cultured hepatoma cells in which it is under multihormonal control (16, 18, 36) . We hypothesized that cAspAT would also be regulated in adipocytes and that nutritional conditions known to alter liver expression of cAspAT would also modify its adipose expression. To address that question, we fed rats with a diet containing either a high or a low proportion of carbohydrates and analyzed adipose cAspAT mRNA by Northern blot. Rats fed an LC diet presented a 2-to 3-fold higher concentration of cAspAT mRNA than the high carbohydrate (HC) fed rats ( Fig 1A) . Conversely, the change of regimen from LC to HC (LC/HC) for 24 h resulted in a significant lowering of cAspAT mRNA. Similar results could be observed when PEPCK was the target mRNA while S14 mRNA responded in an opposite manner (Fig. 1A) as expected (37, 38) .
In addition to changes in glycemia, variations in the insulin/glucagon ratio and eventually in plasma glucocorticoids, occur between HC and LC fed rats (39) . To determine which of these parameters could be the main regulator of cAspAT gene expression, we used the 3T3-F442A adipocyte cell line (40), a cell culture system widely used for gene regulation studies (41) . When differentiated cells were deprived of glucose for 24 h, cAspAT mRNA was strongly elevated while it remained fairly constant when cells were treated with the cAMP analog 8-(4-chlorophenylthio)-cAMP (8-CPT-cAMP), the glucocorticoid analog dexamethasone or insulin, showing that glucose was the main effector (Fig. 1B) .
The induction of cAspAT gene expression by glucose deprivation is specific to adipocytes
cAspAT is expressed in vivo in all cells analyzed so far in agreement with its ubiquitous function. To assess whether cells other than 3T3-F442A adipocytes would regulate cAspAT mRNA, we analyzed the glucose effect in a series of cultured cell systems. The BFC-1 adipose cell line (30) and primary adipocytes are two model systems of adipocytes for studying hormonal and nutritional controls of gene expression (41, 42) . After differentiation, 3T3-F442A, BFC-1 or primary adipocytes were maintained for 24 h either in glucosesupplemented (25 mm) or in glucose-free medium before RNA isolation and Northern blot analysis with a cAspAT cDNA probe. A large increase in cAspAT mRNA occurred in glucose-starved cells (Fig. 2) . This increase was specific to the cAspAT message because glucose deprivation did not notably affect mAspAT or actin mRNAs (Fig. 2) . None of the nonadipose cell lines, the H4IIE and Fao hepatoma cells, the C2.7 differentiated myocytes or the 293 human transformed kidney cells, responded to glucose deprivation by a change in cAspAT mRNA (Fig. 2) .
We next focused on 3T3-F442A adipocytes and analyzed the time course of glucose action. As shown in Fig. 3 , cAspAT transcript raised in response to glucose deprivation in a time-dependent manner with a 4-fold increase attained at 48 h. This increase was followed by a parallel change in cAspAT enzymatic activity, which reached a specific activity of 75 mU/mg protein at 72 h, corresponding to an increase of about 2-fold above basal (Fig. 3) . Glucose addition to the medium of cells deprived of glucose for 24 h repressed the cAspAT message with a maximal 80% decrease at 8 h, showing that the glucose effect was fully reversible (Fig. 3, inset) . A treatment time of 8 h was chosen to investigate the dose dependence of the glucose effect. Glucose-induced decrease in cAspAT mRNA was dose dependent with a maximum reached at 4.5 g/liter and a half-maximum effect (EC 50 ) attained at about 1.25 g/liter (Fig. 4) .
FIG. 1.
Effect of nutrients and hormones on cAspAT mRNA in rat adipose tissue and in 3T3-F442A adipocytes. A, Three groups of six rats were fed ad libitum for 11 days by either an HC diet, an LC diet, or an LC diet for 10 days followed by 24 h of HC diet (LC/HC). RNA was extracted from periepidydimal adipose tissue and analyzed by Northern blot. Data obtained by scanning densitometry, was normalized for RNA loading using the ␤-Actin mRNA signal. Data are expressed in percentage of HC diet taken as control. B, Differentiated 3T3-F442A adipocytes were cultured in medium A (CTL) then shifted for 24 h in glucose-free, serum-free medium (-glucose) or in serum-free medium supplemented with either 8-CPT-AMPc (500 M), dexamethasone (100 nM), or insulin (1 M). mAspAT and cAspAT mRNA were analyzed by Northern blot.
Effects of various hexoses or glucose analogs on cAspAT gene expression in 3T3-F442A adipocytes
To exclude the possibility that differences in cAspAT gene expression were due to differences in osmotic pressure between cells cultured in the presence and in the absence of glucose, 3T3-F442A adipocytes were treated with either 4.5 g/liter of [scap[l-glucose or 4.5 g/liter of mannitol, two sugars that are not transported into cells. Neither l-glucose nor mannitol affected the cAspAT gene expression (Fig. 5) . Hence, the glucoseinduced inhibition of cAspAT gene expression was not due to an osmotic change of the culture medium.
Next, we aimed at elucidating whether glucose or one of its metabolites was responsible for the observed effect. We treated 3T3-F442A adipocytes with various glucose analogs and analyzed the cAspAT mRNA content. Galactose or 3-orthomethyl-glucose (3-OMG), two sugars that are transported but not metabolized were inefficient (Fig. 5) . Fructose or mannose reduced cAspAT mRNA with a magnitude equivalent to that induced by d-glucose (60 -70%), showing that glucose action required transport and metabolism (Fig. 5) . 2-deoxyglucose (2-DOG), which is transported and phosphorylated into 2-deoxyglucose 6-phosphate but not further metabolized through the glycolytic pathway, fully mimicked d-glucose, demonstrating that glucose phosphorylation was necessary and sufficient for reducing cAspAT mRNA content (Fig. 5) . 2-DOG-6-phosphate could be further metabolised in the pentose phosphate pathway. Therefore, we tested xylitol, an intermediate of the nonoxydative branch of the pentose phosphate pathway, able to mimic glucose induction of L-pyruvate kinase gene expression in hepatocytes (43) . Xylitol at concentrations of either 25 mm (Fig. 5) , 10 mm or 0.5 mm (not shown) did not affect cAspAT mRNA. These data indicated that glucose-6-phosphate was the likely intermediate of glucose in inhibiting cAspAT gene expression. 
Mechanism of the regulation by glucose of cAspAT gene expression
We wondered whether the glucose effect was direct or indirect. Before glucose treatment, we treated glucosedeprived cells with the protein synthesis inhibitor cycloheximide, at concentrations previously shown to inhibit protein synthesis (11, 26) . Cycloheximide alone did not affect cAspAT mRNA, whereas it prevented almost totally the glucose-elicited inhibition of cAspAT gene expression (Fig.  6A ). This glucose effect was also prevented in the presence of anisomycin (not shown). We conclude that glucose action did require protein synthesis.
Changes in steady-state mRNA concentrations can be the result of variations in mRNA stability. To determine whether mRNA half-life could be affected by glucose treatment, we incubated glucose-deprived 3T3-F442A adipocytes with or without glucose in the presence of 25 g/ml of the transcription inhibitor 5,6-dichlorobenzimidazole riboside (DRB) and evaluated the time-dependent cAspAT mRNA decrease by Northern blot. As shown in Fig. 6B , cAspAT mRNA degradation rate was similar whether cells were incubated or not in the presence of glucose. Thus, glucose did not change cAspAT mRNA half-life, strongly suggesting that cAspAT gene transcription rate was the regulated step.
To determine whether the glucose effect was mediated by the promoter region of the cAspAT gene, we used the p-2405/-26:CAT construct previously shown to be hormoneresponsive when transfected into Fao hepatoma cells (19) . This construct contains the Ϫ2405 to Ϫ26 bp relative to the translation start site of the cAspAT gene fused to the chloramphenicol acetyltransferase reporter gene. We cotransfected 3T3-F442A adipoblasts with p-2405/-26:CAT and pSV2-NEO which conferred resistance of the transfected cells to the neomycin analog geneticin (G418). Twelve individual clones were randomly selected. Eleven retained the ability to differentiate into adipocytes. Among these stably transfected clones, five expressed CAT at a substantial level, with specific activities ranging from 2.4 to 35 mU/mg protein after adipocyte differentiation (Fig. 7) . All these clones responded to a 24-h glucose deprivation by an increase in CAT activity although to a variable extent (1.4-to 6.2-fold) (Fig. 7) . In contrast, two previously characterized stable transfectants bearing Ϫ2100 to ϩ69 bp of the phosphoenolpyruvate carboxykinase gene promoter fused to the CAT gene (PEPCK-CAT) (44) did not respond to glucose deprivation by a significant change in CAT gene expression (Fig. 7) . Therefore, the 5Ј-flanking region of the cAspAT gene promoter specifically contains a negative glucose-response region.
Identification of the negative glucose-response region in the cAspAT gene promoter
We stably transfected 3T3-F442A cells with various 5Ј deletions of the cAspAT gene promoter driving CAT. For each deletion, at least five stable clones were analyzed for their response to a 24 h glucose deprivation. Results in Fig. 8 are presented as the mean increase in CAT activity by glucose deprivation. A deletion from Ϫ1984 to Ϫ1718 bp of the promoter abolished glucose response showing that a glucoseresponse element(s) was present in that fragment of the promoter. Glucose response was also abolished with a shorter construct (Fig. 8) .
The role of the glucose-responsive DNA fragment was further confirmed by the construction of two plasmids bearing Ϫ1984 to Ϫ1702 bp of the cAspAT gene at the 5Ј-end position of either the thymidine kinase (TK) promoter or the ⌬MTV promoter, which was deleted of the steroid response region of the wild-type mouse mammary tumor virus long terminal repeat. Stable transfectants were obtained and tested for their glucose response. The p-1984/-1702⌬MTV: CAT and p-1984/-1702TK:CAT both responded to glucose deprivation by a 1.7-fold increase (P Յ 0.05) in CAT activity, whereas ⌬MTV was unaffected and TK-driven CAT expression was slightly repressed (data not shown). Such a blunted response when using a heterologous promoter is a frequently observed phenomenon that can be due to the difference in the positioning of the cis-element relative to the transcription start site of the transgene. Similar experiments were then carried out using a shorter fragment (Ϫ1838 to Ϫ1702 bp) of the cAspAT gene placed at the 5Ј-end of the TK gene (p-1838/-1702TK:CAT). Stable p-1838/-1702TK:CAT/3T3-F442A transfectants responded to glucose deprivation by a 2.6-fold increase in CAT activity. Hence, a glucose-response element(s) is present in the fragment of the cAspAT gene promoter between Ϫ1838 and Ϫ1702 bp. However, we cannot exclude that another region of the gene also plays a role in the regulation by glucose.
Analysis of protein-DNA interactions in the glucose-response region of the cAspAT gene promoter
The Ϫ1838/Ϫ1702 fragment of the cAspAT gene promoter was analyzed by DNAseI footprinting using nuclear extracts from glucose-treated or glucose-deprived cells. Several footprints were observed showing that this region contains binding sites for adipocyte nuclear proteins (Fig. 9) . The regions spanning the sequence Ϫ1747/Ϫ1729 and Ϫ1720/Ϫ1702 were totally protected. A large region extending from Ϫ1835 to Ϫ1759 was only partially protected and included a hypersensitive site at Ϫ1799. A similar pattern was observed on the noncoding strand. There was no significant difference between the binding patterns of nuclear extracts from glucose-treated or glucose-deprived cells. Such an absence of modification is not entirely surprising because it has been reported for either footprinting or gel retardation assays in several cases (45) (46) (47) (48) (49) . This suggests that glucose regulates the transactivation properties of the transcription factor(s) rather than its binding properties to DNA.
Discussion
Cytosolic AspAT has been shown to be regulated in liver by several hormones and during development (19) . These regulations are mediated by the cAspAT gene promoter. Nutrients also play an important role in the regulation of this gene, although the targeted tissue is different. Indeed, physiological concentrations of glucose repress the cAspAT gene expression in adipocytes but not in several other cell lines that we have tested, including hepatoma cell lines. Thus, while the basal expression of this gene is ubiquitous, its regulation by glucose appears to be cell specific, at least within all the culture systems that we tested, and in this respect is similar to its regulation by hormones such as glucocorticoids and insulin. However, a major difference between the two types of regulations is that the hormonal effects are essentially hepatocyte-specific, whereas the glucose effect is adipocyte-specific. Furthermore, both the hormonal and the glucose effects are gene-specific, in that only the cytosolic isoform of AspAT and not the mitochondrial one is regulated.
In adipocytes, cAspAT could contribute to glyceroneogenesis by generating oxaloacetate in the cytoplasm. It is well known that a carbohydrate-rich diet would tend to repress this metabolic pathway. In the case of cAspAT, our results suggest that this may occur through increased glycemia. The regulation of PEPCK, another enzyme involved in glyceroneogenesis, is more complex as it has been shown to be repressed by glucose in adipose tissue explants in culture (10), but not in 3T3-F442A adipocytes (11) . Nevertheless, in the latter cells, glucose inhibits fatty acid-induced PEPCK gene expression (11) . Furthermore, insulin represses induction of PEPCK mRNA by cAMP in these cells (50) .
We have found no evidence for the regulation of the cAspAT gene expression by insulin in 3T3-F442A adipocytes. In contrast, this hormone represses this gene in hepatic cells. Thus, increased glucose intake has a negative effect on cAspAT gene expression in both liver and adipocytes, but through different mechanisms. In the latter case, it acts directly through a glucose metabolite, while in the former case, it acts through the increase in insulin concentration that is associated with it. In this respect, it is interesting to note that the same promoter region contains elements responsible for the negative effects of both insulin and glucose. It is not known yet whether signaling by both compounds converge on the same DNA element or on the same transcription factor, and we cannot exclude that glucose acts also through other sequences.
Few other genes encoding metabolic enzymes have been shown to be regulated by glucose in adipose tissue. The most studied ones are those encoding fatty acid synthase and acetylCoA carboxylase. However, unlike cAspAT, both genes are induced by glucose (10, 12) . In hepatic cells, Lpyruvate kinase, Spot 14, aldolase B, and glucose-6-phosphatase mRNAs are induced by glucose (6, 7, (51) (52) (53) . Among genes encoding metabolic proteins, glucose has been shown to repress the Glut 1 glucose transporter. However, unlike cAspAT, the repression of Glut 1 can be observed in several different cell types (54) . The mechanism of glucose action has been investigated at least in the case of fatty acid synthase in adipocytes and L-pyruvate kinase in liver cells. In both cases, glucose-6-phosphate has been shown to mediate the glucose effect. This is also what we have demonstrated for cAspAT gene regulation (Fig 5) . Identically, our result suggests that phosphorylation of glucose is critical for its transcriptional action on the cAspAT gene. In contrast to what has been observed for L-pyruvate kinase (43), glucose-6-phosphatase (55) and fatty acid synthase and S14 genes (56) in hepatocytes, xylitol does not reproduce glucose action on cAspAT gene expression in adipocytes. Thus, we have no evidence that the pentose phosphate pathway may be involved in our case.
The mechanism of action of phosphorylated glucose on the inhibition of the cAspAT gene transcription is not likely the result of the direct activation of a preexisting transcription factor because gene inhibition is relatively delayed with respect to glucose addition to the culture medium (6 h) and is blocked by protein synthesis inhibitors. Further investigations will determine whether glucose 6-phosphate acts by itself on a primary responsive gene, mediating its effect on cAspAT gene, or whether it interferes in some way with the intracellular metabolism generating other metabolites that could be the actual transcription activators.
The regulatory gene, gadd153 has been shown to be under negative control by glucose in adipocytes (57) . Gadd153, also referred to as CHOP-10, is a dominant negative inhibitor of the transcription factors CAAT/enhancer-binding protein (C/EBP) and the liver-enriched transcriptional activator protein (LAP) (58) . This could be of particular interest with regard to the glucose regulation of the cAspAT gene because its basal promoter is activated by C/EBP (35) . However, we have shown that the 300 bp proximal promoter fragment that contains high affinity C/EBP sites is not regulated by glucose (Fig. 7) . The region responsible for glucose regulation is distal (Ϫ1838 to Ϫ1702) and contains consensus sequences for the activator protein 1 (AP1) and the helix-loop-helix (HLH) family of transcription factors and degenerated sequences for recognition of the octamer proteins, hepatocyte nuclear factor 3 (HNF3) and C/EBP. As mentioned, this complex region also mediates the hormonal regulation of cAspAT in hepatocytic cells in addition to its nutritional regulation (19) . We are currently investigating the contribution of the various sites and the possible convergence of the various regulations on the same sites. 
